Can Morphine 20mg Be Placed in a Syringe Driver?
Yes, morphine 20mg can absolutely be placed in a syringe driver for continuous subcutaneous infusion—this is an established and guideline-supported method for delivering morphine, particularly in palliative care settings. 1
Route and Administration Method
Morphine may be given subcutaneously either as bolus injections every four hours or by continuous infusion via syringe driver. 1
Subcutaneous administration is the preferred alternative route when patients cannot take drugs orally, alongside rectal administration. 1
The oral to subcutaneous morphine potency ratio is approximately 1:2, meaning subcutaneous morphine is roughly twice as potent as oral morphine. 1
Practical Considerations for Syringe Driver Use
Dose Conversion
- If converting from oral morphine, divide the total daily oral dose by 2 to get the subcutaneous equivalent. 1
- For example, 60mg oral morphine daily = 30mg subcutaneous morphine daily via continuous infusion. 1
Stability and Preparation
Morphine sulfate solutions (2mg/mL and 15mg/mL) remain stable for at least 12 days in disposable infusion devices and plastic syringes at room temperature (23-25°C), 4°C, and 31°C. 2
Morphine solutions are more stable in normal saline than in 5% dextrose, with shelf-life data indicating stability for at least 6 weeks when protected from light. 3
Subcutaneous morphine infusion by syringe driver for terminally ill patients provides effective pain control without increasing mortality risk or shortening survival. 4
Clinical Context
Continuous subcutaneous infusions by syringe driver are used successfully in terminal care when drugs cannot be given orally. 5
In the UK, diamorphine is often preferred over morphine for syringe drivers due to its higher solubility, allowing smaller infusion volumes. 1, 5
However, morphine remains entirely appropriate and effective when diamorphine is unavailable. 1
Contraindications to Subcutaneous Administration
Subcutaneous morphine administration may not be practical in patients with: 1
- Generalized edema, soreness, or sterile abscesses
- Erythema at injection sites
- Coagulation disorders
- Very poor peripheral circulation
Key Clinical Pitfalls
Do not use intramuscular administration for chronic cancer pain—subcutaneous is simpler and less painful. 1
Ensure accurate volume calculations when preparing infusions, as lack of appreciation for volume overage in morphine ampoules can lead to concentration errors exceeding 20% in some cases. 6
Monitor patients with renal insufficiency closely, as morphine-6-glucuronide (an active metabolite) accumulates and may worsen adverse effects. 7
The 20mg dose you mention should be considered in context of the total daily dose and patient opioid tolerance—ensure this represents an appropriate portion of the 24-hour requirement. 1